In all countries, hospital-acquired infections are a growing source of preventable disease burden in terms of morbidity and mortality. It has a significant negative impact on healthcare costs, particularly in developing countries. The cost may be direct (the cost of medicines, bed occupation, etc.) or indirect (as patients are deprived of work). According to a WHO study, 55 hospitals in 14 countries in Southeast Asia, Europe, the Eastern Mediterranean, and the Western Pacific revealed that, on average, 8.7% of hospital patients suffer nosocomial infections.
Globally, at least 1 in 4 patients in intensive care will acquire an infection during their stay in the hospital. As a result, strict guidelines are being provided to prevent and control hospital infection. The WHO and various other regulatory bodies at regional and national levels provide guidelines for hospital infection prevention and control. The rising prevalence of nosocomial infections and regulatory guidelines and measures are the driving factors of the global hospital infection prevention and control market.
The report titled "Global Hospital Infection Prevention and Control Market: Growth, Share, Opportunities, and Competitive Analysis, 2016–2024" offers strategic insights into the overall hospital infection prevention and control market, along with the market size and estimates for the duration of 2016–2024.
The said research study covers an in-depth analysis of multiple market segments based on the type of infection, products, and different geographies. The infection type segment studied for analyzing the overall global hospital infection prevention, and control market is majorly segmented into pneumonia, urinary tract infection, bloodstream infection, surgical site infection, MRSA, and others. The product type segment studied for analyzing the global hospital infection prevention and control market is majorly segmented into infection prevention supplies, infection prevention equipment, and infection prevention services.
Geographically, the global hospital infection prevention and control market is studied for the following regional markets:
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia-Pacific
China
Japan
Rest of Asia Pacific
Latin America
Mexico
Brazil
Rest of LATAM
Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2014–2024. Market growth rates for the forecast period 2016–2024 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global hospital infection prevention and control market.
Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the competitive landscape of the global hospital infection prevention and control market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global hospital infection prevention and control market. In-depth competitive environment analysis and historical (2014) market size data are also provided in the report.
Based on the type of product, the global hospital infection prevention and control market is segmented as follows:
Infection Prevention Supplies
Disinfectants
Protective apparel and textiles
Safety-Enhanced Medical Devices
Sterilization Supplies
medical waste disposal supplies
Infection Prevention Equipment
Endoscope Reprocessors
Sterilization Equipment
Washing/Disinfecting Equipment
other infection prevention equipment
Infection Prevention Services
medical waste disposal services
contract sterilization services
Infection Prevention Equipment
Infection Prevention Services
In 2015, infection prevention supplies held the largest share of the overall hospital infection prevention and control market. The disinfectants market is expanding as the importance of infection control and sterilization policies in hospitals grows, as make government regulations govern healthcare services. The protective apparel and textile market held the largest share in the infection prevention supplies market due to aggressive efforts by hospitals to reduce the risk of hospital-acquired infections in surgery and other invasive procedures.
As infection-control equipment continues to play an important role in the prevention of infection transmission in the healthcare settings infection prevention services include regular infection prevention activities within the hospital that work closely with the microbiology laboratory and other critical medical departments. The major types of infection prevention services include medical waste disposal and contract sterilization services.
Based on the type of infection, the global hospital infection and control market is segmented as follows:
Pneumonia
Infection of the Urinary Tract
bloodstream infection
Surgical site infection
MRSA
Others
Pneumonia, urinary tract infection (UTI), surgical site infection (SSI), and MRSA are the major types of hospital-acquired infections with the highest prevalence. As sourced by the CDC, ventilator-associated pneumonia and surgical site infection are the most common conditions, followed by GI infection, UTI, and primary bloodstream infection.
The CDC also reported that device-associated infections such as pneumonia, catheter-associated UTIs, and central catheter-associated bloodstream infections accounted for one-fourth of total HAIs. Approximately half of HAIs are device-associated and surgical site infections, and the rest are not linked to devices or operative apparatuses.
For the purpose of this study, the global hospital infection and control market is geographically categorized into:
North America
Europe
Asia Pacific
Latin America (LATAM)
Middle East and Africa (MEA)
Due to the rising prevalence of nosocomial infections and stringent regulations followed by hospitals, clinicians, and caregivers aligning with regulatory bodies, North America formed the largest regional market for hospital infection prevention and control in 2015. With increased awareness of healthcare-associated infection, rising investment in healthcare infrastructure, technological advancement, and new protocols and programs for infection prevention and control in accordance with WHO guidelines, Asia Pacific is the fastest-growing segment.
Frequently Asked Questions:
The market for Hospital Infection Prevention And Control Market is expected to reach US$ 245.6 By 2024.
The Hospital Infection Prevention And Control Market is expected to see significant CAGR growth over the coming years, at 6.3%.
The report is forecasted from 2016-2024.
The base year of this report is 2015.
Ansell Ltd., Cantel Medical Corp., Halyard Health, Inc., Synergy Health plc., Purdue Pharma LP are some of the major players in the global market.
